Finding solutions for the endless wait - reducing waiting times for radiotherapy

Radiotherapy and Oncology

Volumn 87, Issue 1, 2008, Pages 153-154

  Agarwal, Jai Prakash ^a   Ghosh Laskar, Sarbani ^a   Budrukkar, Ashwini ^a   Murthy, Vedang ^a   Mallick, Indranil ^a  

^a TATA MEMORIAL HOSPITAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

BONE METASTASIS; CANCER CONTROL; CANCER RADIOTHERAPY; DEVELOPING COUNTRY; DISEASE FREE SURVIVAL; EVIDENCE BASED MEDICINE; EXTERNAL BEAM RADIOTHERAPY; HEAD AND NECK CANCER; HEALTH CARE MANPOWER; HOSPITAL ADMISSION; HUMAN; LARYNX CANCER; LETTER; PATIENT SELECTION; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; TREATMENT DURATION; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; DISEASE PROGRESSION; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; TIME FACTORS; TUMOR BURDEN; WAITING LISTS;

EID: 41849089365     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2007.11.021     Document Type: Letter

References (12)

1. Jensen A.R., Nellemann H.M., and Overgaard J. Tumor progression in waiting time for radiotherapy in head and neck cancer. Radiother Oncol 84 (2007) 5-10
2. Datta N.R., and Rajasekar D. Improvement of radiotherapy facilities in developing countries: a three-tier system with a teleradiotherapy network. Lancet Oncol 5 (2004) 695-698
3. Mackillop W.J., Bates J.H., O'Sullivan B., and Withers H.R. The effect of delay in treatment on local control by radiotherapy. Int J Radiat Oncol Biol Phys 34 (1996) 243-250
4. Mackillop W.J. Killing time: the consequences of delays in radiotherapy. Radiother Oncol 84 (2007) 1-4
5. Overgaard J., Hansen H.S., Specht L., et al. Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6 and 7 randomised controlled trial. Lancet 362 (2003) 933-940
6. Overgaard J, Mohanti B, Bhaskar S, et al. Accelerated versus conventional fractionated radiotherapy in squamous cell carcinoma in head and neck (SCCHN), a randomized International Multicenter Trial with 908 patients conducted by the IAEA-ACC study group. Int J Radiat Oncol Biol Phys 2006; 66(3).
7. Dinshaw K.A., Sharma V., Agarwal J.P., Ghosh S., and Havaldar R. Radiation therapy in T1-T2 glottic carcinoma: influence of various treatment parameters on local control/ complications. Int J Radiat Oncol Biol Phys 48 (2000) 723-735
8. Gowda R.V., Henk J.M., Mais K.L., Sykes A.J., Swindell R., and Slevin N.J. Three weeks radiotherapy for T1 glottic cancer: the Christie and Royal Marsden Hospital Experience. Radiother Oncol 68 (2003) 105-111
9. Whelan T., MacKenzie R., Julian J., et al. Randomized trial of breast irradiation schedules after lumpectomy for women with lymph node-negative breast cancer. J Natl Cancer Inst 94 (2002) 1143-1150
10. Owen J.R., Ashton A., Bliss J.M., et al. Effect of radiotherapy fraction size on tumour control in patients with early-stage breast cancer after local tumour excision: long-term results of a randomised trial. Lancet Oncol 7 (2006) 467-471
11. Williams S.G., Taylor J.M., Liu N., et al. Use of individual fraction size data from 3756 patients to directly determine the alpha/beta ratio of prostate cancer. Int J Radiat Oncol Biol Phys 68 (2007) 24-33
12. Sze WM, Shelley M, Held I, Mason M. Palliation of metastatic bone pain: single fraction versus multifraction radiotherapy. Cochrane Database of Systematic Reviews 2002, Issue 1. Art. No.: CD004721. DOI: 0.1002/14651858.CD004721.